Compare FLC & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLC | KRMD |
|---|---|---|
| Founded | 2003 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 186.3M |
| IPO Year | N/A | N/A |
| Metric | FLC | KRMD |
|---|---|---|
| Price | $17.39 | $6.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.88 |
| AVG Volume (30 Days) | 37.8K | ★ 215.8K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,070,637.00 |
| Revenue This Year | N/A | $23.36 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $12.62 | $1.86 |
| 52 Week High | $15.45 | $6.61 |
| Indicator | FLC | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 69.18 |
| Support Level | $17.31 | $5.48 |
| Resistance Level | $17.68 | $6.61 |
| Average True Range (ATR) | 0.15 | 0.34 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 37.78 | 77.84 |
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).